| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eliem Therapeutics, Inc. | 10%+ Owner | Common Stock | 5,009,400 | $62,617,500 | $12.50 | 12 Aug 2021 | Direct |
| Eliem Therapeutics, Inc. | 10%+ Owner | Series A Redeemable Convertible Preferred Stock | 0 | 12 Aug 2021 | Direct | ||
| Eliem Therapeutics, Inc. | 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | 12 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLYM | Eliem Therapeutics, Inc. | 12 Aug 2021 | 4 | +$10,000,000 | 4 | 10%+ Owner | 16 Aug 2021, 16:21 |
| CLYM | Eliem Therapeutics, Inc. | 09 Aug 2021 | 0 | $0 | 3 | 10%+ Owner | 09 Aug 2021, 21:01 |